General Assembly Resolution # 103
A resolution to promote funding and the development of education and the arts.
Category: Education and Creativity
Area of Effect: Educational
Proposed by: Mousebumples
UNDERSTANDING that safety and efficacy are important standards with regards to drug therapy.
ACKNOWLEDGING that a drug may cause varying benefits and side effects in different species.
DESIRING to more fully understand the inherent benefits and harms with regards to taking drugs.
CREATES the International Drug Education Agency (IDEA) as a sub-committee of the World Assembly Food and Drug Regulatory Agency (WAFADRA).
SPECIFIES that IDEA will collect drug-related research data regarding medical and recreational drug use.
STIPULATES that drug information regarding drug procurement and/or creation will not be gathered by IDEA, unless granted by the holder of the intellectual property rights for said information.
ESTABLISHES the Database Of Clinical Treatments Under Study (DOCTUS) as a drug education branch of the Universal Library Coalition (ULC);
1. IDEA will archive all research data within DOCTUS;
(a) Data from completed but unpublished studies will be included in the archive.
(b) No identifying patient information will be included in the archive.
2. Said data will be made available to, at minimum, all medical professionals within WA nations; individual nations may provide this information to others within their own borders as they deem appropriate.
3. All research data within DOCTUS will be accompanied by a link to the relevant journal article(s), if the research has been published;
(a) IDEA will provide appropriate monetary reimbursement to journals that are not currently archived in the ULC so that their research can be accessed through DOCTUS by credentialed individuals.
(b) If a journal and/or individual article is not available through DOCTUS or the ULC, appropriate citations will be listed.
4. Non-WA nations may apply for access to DOCTUS; a nominal fee may charged by the IDEA for access.
DETAILS that IDEA medical professionals will publish quarterly IDEA newsletters;
1. The newsletters will be written by health care professionals and will detail the most significant discoveries in drug therapy, such as new indications for an already discovered drug, new concerns regarding side effects for an established drug, new recommendations for use in certain populations, etc.
(a) Any recommendations issued by IDEA professionals regarding changes to currently established medication therapy standards will be non-binding.
(b) Scientists will be encouraged to pursue further research regarding published information to ensure that the most effective and appropriate recommendations are in place.
2. The IDEA Quarterly will be provided to all interested nations free of charge and will be archived within DOCTUS with the appropriate reference citations.
RECOMMENDS that Health Research & Development Division of the WHA accept applications for funding from WA member nations for further research regarding already discovered medication therapies to better understand their safety and efficacy with long-term use;
1. Applications for funding must include details of how the study would be conducted and what drug(s) would be studied.
2. Funded studies must receive the informed consent of all participants in the study.
3. Studies are strongly encouraged to have a control group of some nature.